ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,473,264, issued on Nov. 18, was assigned to Purdue Research Foundation (West Lafayette, Ind.).

"Inhibitors of erythrocyte band 3 tyrosine phosphorylation and uses thereof" was invented by Philip Stewart Low (West Lafayette, Ind.), Daniel A. Sheik (Lafayette, Ind.) and Som Dutt (Shamli Uttar, India).

According to the abstract* released by the U.S. Patent & Trademark Office: "Inhibitors of erythrocyte band 3 tyrosine phosphorylation of formula (I), and pharmaceutical salts thereof, are described:wherein R1-R3 are defined herein. Compositions comprising compounds of the formula (I), and methods of using the compounds and compositions comprising the compounds to treat sickle cell disease...